Growth Metrics

Gilead Sciences (GILD) Assets Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.28%
Dec 31, 2025 0.05%
Sep 30, 2025 7.35%
Jun 30, 2025 4.00%
Mar 31, 2025 0.25%
Dec 31, 2024 -5.04%
Sep 30, 2024 -12.58%
Jun 30, 2024 -14.05%
Mar 31, 2024 -9.02%
Dec 31, 2023 -1.66%
Sep 30, 2023 -0.29%
Jun 30, 2023 -0.85%
Mar 31, 2023 -1.91%
Dec 31, 2022 -7.04%
Sep 30, 2022 -6.77%
Jun 30, 2022 -7.52%
Mar 31, 2022 -6.54%
Dec 31, 2021 -0.67%
Sep 30, 2021 10.22%
Jun 30, 2021 21.54%
Mar 31, 2021 12.97%
Dec 31, 2020 11.00%
Sep 30, 2020 2.93%
Jun 30, 2020 -11.51%
Mar 31, 2020 -4.93%
Dec 31, 2019 -3.22%
Sep 30, 2019 -8.02%
Jun 30, 2019 -3.28%
Mar 31, 2019 -3.89%
Dec 31, 2018 -9.40%
Sep 30, 2018 -0.55%
Jun 30, 2018 8.45%
Mar 31, 2018 13.31%
Dec 31, 2017 23.35%
Sep 30, 2017 14.23%
Jun 30, 2017 20.57%
Mar 31, 2017 20.80%
Dec 31, 2016 10.17%
Sep 30, 2016 11.79%
Jun 30, 2016 27.61%
Mar 31, 2016 24.64%
Dec 31, 2015 49.19%
Sep 30, 2015 75.55%
Jun 30, 2015 25.51%
Mar 31, 2015 36.48%
Dec 31, 2014 53.52%
Sep 30, 2014 28.38%
Jun 30, 2014 37.93%
Mar 31, 2014 26.41%
Dec 31, 2013 6.30%
Sep 30, 2013 7.18%
Jun 30, 2013 10.35%
Mar 31, 2013 11.33%
Dec 31, 2012 22.75%
Sep 30, 2012 65.85%
Jun 30, 2012 61.51%
Mar 31, 2012 53.61%
Dec 31, 2011 49.26%
Sep 30, 2011 10.34%
Mar 31, 2011 21.42%
Dec 31, 2010 19.53%
Sep 30, 2010 28.18%